Clovis Oncology, Inc. CLVS
Set alert
0.08 +0.08 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 11.77M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.10
- Beta
- 0.22
- Short ratio
- 4.63
- Inst. own
- 25.90%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2022
- 50-d avg
- 0.517402
- 200-d avg
- 1.26
- 1y target
- 2.00
3M chart
Events in this range
- Nov 9, 2022Earnings: —; estimate -0.42; surprise —%
- Nov 10, 2022Downgrade: JP Morgan · Neutral → Underweight
Signals (12)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Dec 5, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 28, 2022 | 3 years ago |
| RSI: Oversold | Nov 9, 2022 | 3 years ago |
| MACD: Sell Signal | Oct 31, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 28, 2022 | 4 years ago |
| MACD: Sell Signal | Oct 24, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 17, 2022 | 4 years ago |
| MACD: Sell Signal | Oct 12, 2022 | 4 years ago |
| SMA: Bearish | Oct 7, 2022 | 4 years ago |
| SMA: Bullish | Oct 3, 2022 | 4 years ago |
| MACD: Buy Signal | Sep 29, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 26, 2022 | 4 years ago |
Ownership
Held by insiders 1.44%
Held by institutions 25.90%
Float held by institutions 26.28%
Institutions 142
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group, Inc. (The) | 7.04% | 10,206,509 | 828.77K | Sep 29, 2022 |
| Palo Alto Investors Lp | 3.09% | 4,473,967 | 363.29K | Sep 29, 2022 |
| Blackrock Inc. | 2.78% | 4,035,344 | 327.67K | Sep 29, 2022 |
| QVT Financial LP | 2.43% | 3,525,000 | 286.23K | Sep 29, 2022 |
| Renaissance Technologies, LLC | 1.52% | 2,209,700 | 179.43K | Sep 29, 2022 |
| Geode Capital Management, LLC | 0.95% | 1,382,968 | 112.30K | Sep 29, 2022 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.00% | 4,343,267 | 352.67K | Sep 29, 2022 |
| Vanguard Extended Market Index Fund | 1.32% | 1,917,512 | 155.70K | Sep 29, 2022 |
| Vanguard Strategic Equity Fund | 1.16% | 1,679,012 | 136.34K | Sep 29, 2022 |
| Vanguard Explorer Fund, Inc. | 0.99% | 1,439,253 | 116.87K | Jul 30, 2022 |
| iShares NASDAQ Biotechnology ETF | 0.80% | 1,166,483 | 94.72K | Nov 29, 2022 |
| Fidelity Extended Market Index Fund | 0.52% | 747,376 | 60.69K | Oct 30, 2022 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| GROSS PAUL EDWARD | General Counsel | Sale | Nov 1, 2022 | 98,330 |
| HARDING THOMAS C | Officer | Sale | Nov 1, 2022 | 0 |
| IVERS-READ GILLIAN C | Officer | Sale | Nov 1, 2022 | 293,612 |
| MUEHL DANIEL W | Chief Financial Officer | Sale | Nov 1, 2022 | 104,830 |
| ROLFE LINDSEY | Officer | Sale | Nov 1, 2022 | 113,691 |
Held by funds
1 US ETFs and mutual funds hold CLVS · largest positions
| Fund | Value held | Weight in fund |
|---|---|---|
| LOPX | 0.67% |